BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 31514467)

  • 1. The Molecular Mechanism of Epithelial-Mesenchymal Transition for Breast Carcinogenesis.
    Li CJ; Chu PY; Yiang GT; Wu MY
    Biomolecules; 2019 Sep; 9(9):. PubMed ID: 31514467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosstalk between TGF-β signaling and miRNAs in breast cancer metastasis.
    Chen W; Zhou S; Mao L; Zhang H; Sun D; Zhang J; Li J; Tang JH
    Tumour Biol; 2016 Aug; 37(8):10011-9. PubMed ID: 27153853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The roles of TGF-β signaling in carcinogenesis and breast cancer metastasis.
    Imamura T; Hikita A; Inoue Y
    Breast Cancer; 2012 Apr; 19(2):118-24. PubMed ID: 22139728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment.
    Tian H; Liu J; Chen J; Gatza ML; Blobe GC
    Oncogene; 2015 Nov; 34(45):5635-47. PubMed ID: 25823021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition.
    Lv ZD; Kong B; Li JG; Qu HL; Wang XG; Cao WH; Liu XY; Wang Y; Yang ZC; Xu HM; Wang HB
    Oncol Rep; 2013 Jan; 29(1):219-25. PubMed ID: 23129177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-β signaling: Tumorigenesis and targeting for cancer therapy.
    Ahmadi A; Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Aug; 234(8):12173-12187. PubMed ID: 30537043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OVOL2 antagonizes TGF-β signaling to regulate epithelial to mesenchymal transition during mammary tumor metastasis.
    Wu RS; Hong JJ; Wu JF; Yan S; Wu D; Liu N; Liu QF; Wu QW; Xie YY; Liu YJ; Zheng ZZ; Chan EC; Zhang ZM; Li BA
    Oncotarget; 2017 Jun; 8(24):39401-39416. PubMed ID: 28455959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of fibroblasts by nicotine promotes the epithelial-mesenchymal transition and motility of breast cancer cells.
    Chen PC; Lee WY; Ling HH; Cheng CH; Chen KC; Lin CW
    J Cell Physiol; 2018 Jun; 233(6):4972-4980. PubMed ID: 29215705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA NKILA suppresses TGF-β-induced epithelial-mesenchymal transition by blocking NF-κB signaling in breast cancer.
    Wu W; Chen F; Cui X; Yang L; Chen J; Zhao J; Huang D; Liu J; Yang L; Zeng J; Zeng Z; Pan Y; Su F; Cai J; Ying Z; Zhao Q; Song E; Su S
    Int J Cancer; 2018 Nov; 143(9):2213-2224. PubMed ID: 29761481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. cPLA2α mediates TGF-β-induced epithelial-mesenchymal transition in breast cancer through PI3k/Akt signaling.
    Chen L; Fu H; Luo Y; Chen L; Cheng R; Zhang N; Guo H
    Cell Death Dis; 2017 Apr; 8(4):e2728. PubMed ID: 28383549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FUT8 promotes breast cancer cell invasiveness by remodeling TGF-β receptor core fucosylation.
    Tu CF; Wu MY; Lin YC; Kannagi R; Yang RB
    Breast Cancer Res; 2017 Oct; 19(1):111. PubMed ID: 28982386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [TGF-β signaling pathways in cancers].
    Talar B; Czyż M
    Postepy Hig Med Dosw (Online); 2013 Sep; 67():1008-17. PubMed ID: 24088545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The TGF-β signaling pathway induced EMT in breast cancer].
    Ma Y; Liu H; Zhang H; Shao RG
    Yao Xue Xue Bao; 2015 Apr; 50(4):385-92. PubMed ID: 26223118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin reverses the epithelial-mesenchymal transition of pancreatic cancer cells by inhibiting the Hedgehog signaling pathway.
    Sun XD; Liu XE; Huang DS
    Oncol Rep; 2013 Jun; 29(6):2401-7. PubMed ID: 23563640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dichotomous roles of TGF-β in human cancer.
    Huang JJ; Blobe GC
    Biochem Soc Trans; 2016 Oct; 44(5):1441-1454. PubMed ID: 27911726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-190 suppresses breast cancer metastasis by regulation of TGF-β-induced epithelial-mesenchymal transition.
    Yu Y; Luo W; Yang ZJ; Chi JR; Li YR; Ding Y; Ge J; Wang X; Cao XC
    Mol Cancer; 2018 Mar; 17(1):70. PubMed ID: 29510731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis.
    Hao Y; Baker D; Ten Dijke P
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31195692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fusion of macrophages promotes breast cancer cell proliferation, migration and invasion through activating epithelial-mesenchymal transition and Wnt/β-catenin signaling pathway.
    Zhang LN; Huang YH; Zhao L
    Arch Biochem Biophys; 2019 Nov; 676():108137. PubMed ID: 31605677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-β-Smad2 dependent activation of CDC 25A plays an important role in cell proliferation through NFAT activation in metastatic breast cancer cells.
    Sengupta S; Jana S; Bhattacharyya A
    Cell Signal; 2014 Feb; 26(2):240-52. PubMed ID: 24269534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-β at the crossroads of multiple prognosis in breast cancer, and beyond.
    Shukla N; Naik A; Moryani K; Soni M; Shah J; Dave H
    Life Sci; 2022 Dec; 310():121011. PubMed ID: 36179816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.